BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 32051546)

  • 1. Rab5a activates IRS1 to coordinate IGF-AKT-mTOR signaling and myoblast differentiation during muscle regeneration.
    Cong XX; Gao XK; Rao XS; Wen J; Liu XC; Shi YP; He MY; Shen WL; Shen Y; Ouyang H; Hu P; Low BC; Meng ZX; Ke YH; Zheng MZ; Lu LR; Liang YH; Zheng LL; Zhou YT
    Cell Death Differ; 2020 Aug; 27(8):2344-2362. PubMed ID: 32051546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raptor and Rheb negatively regulate skeletal myogenesis through suppression of insulin receptor substrate 1 (IRS1).
    Ge Y; Yoon MS; Chen J
    J Biol Chem; 2011 Oct; 286(41):35675-35682. PubMed ID: 21852229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct amino acid-sensing mTOR pathways regulate skeletal myogenesis.
    Yoon MS; Chen J
    Mol Biol Cell; 2013 Dec; 24(23):3754-63. PubMed ID: 24068326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis.
    Motohashi N; Alexander MS; Shimizu-Motohashi Y; Myers JA; Kawahara G; Kunkel LM
    J Cell Sci; 2013 Jun; 126(Pt 12):2678-91. PubMed ID: 23606743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinesin light chain 1 stabilizes insulin receptor substrate 1 to regulate the IGF-1-AKT signaling pathway during myoblast differentiation.
    Qu Z; Shi L; Wu Z; Lin P; Zhang G; Cong X; Zhao X; Ge H; Yan S; Jiang L; Wu H
    FASEB J; 2024 Feb; 38(3):e23432. PubMed ID: 38300173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation between Shh and IGF-I in promoting myogenic proliferation and differentiation via the MAPK/ERK and PI3K/Akt pathways requires Smo activity.
    Madhala-Levy D; Williams VC; Hughes SM; Reshef R; Halevy O
    J Cell Physiol; 2012 Apr; 227(4):1455-64. PubMed ID: 21618536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110β-deficient myoblasts is mediated by PI3K p110α and mTORC2.
    Matheny RW; Lynch CM; Leandry LA
    Growth Factors; 2012 Dec; 30(6):367-84. PubMed ID: 23137199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive expression of insulin receptor substrate (IRS)-1 inhibits myogenic differentiation through nuclear exclusion of Foxo1 in L6 myoblasts.
    Hakuno F; Yamauchi Y; Kaneko G; Yoneyama Y; Nakae J; Chida K; Kadowaki T; Yamanouchi K; Nishihara M; Takahashi S
    PLoS One; 2011; 6(10):e25655. PubMed ID: 21991327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia converts the myogenic action of insulin-like growth factors into mitogenic action by differentially regulating multiple signaling pathways.
    Ren H; Accili D; Duan C
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5857-62. PubMed ID: 20231451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of protein kinase C theta contributes to enhanced myogenesis in vitro via IRS1 and ERK1/2 phosphorylation.
    Marino JS; Hinds TD; Potter RA; Ondrus E; Onion JL; Dowling A; McLoughlin TJ; Sanchez ER; Hill JW
    BMC Cell Biol; 2013 Sep; 14():39. PubMed ID: 24053798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin F2alpha represses IGF-I-stimulated IRS1/phosphatidylinositol-3-kinase/AKT signaling in the corpus luteum: role of ERK and P70 ribosomal S6 kinase.
    Arvisais E; Hou X; Wyatt TA; Shirasuna K; Bollwein H; Miyamoto A; Hansen TR; Rueda BR; Davis JS
    Mol Endocrinol; 2010 Mar; 24(3):632-43. PubMed ID: 20160123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-1 receptor is regulated by microRNA-133 during skeletal myogenesis.
    Huang MB; Xu H; Xie SJ; Zhou H; Qu LH
    PLoS One; 2011; 6(12):e29173. PubMed ID: 22195016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients.
    Erbay E; Park IH; Nuzzi PD; Schoenherr CJ; Chen J
    J Cell Biol; 2003 Dec; 163(5):931-6. PubMed ID: 14662739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNA-199a-3p regulates C2C12 myoblast differentiation through IGF-1/AKT/mTOR signal pathway.
    Jia L; Li YF; Wu GF; Song ZY; Lu HZ; Song CC; Zhang QL; Zhu JY; Yang GS; Shi XE
    Int J Mol Sci; 2013 Dec; 15(1):296-308. PubMed ID: 24378853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsp70 Interacts with Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinase 2 To Regulate p38MAPK Stability and Myoblast Differentiation during Skeletal Muscle Regeneration.
    Fan W; Gao XK; Rao XS; Shi YP; Liu XC; Wang FY; Liu YF; Cong XX; He MY; Xu SB; Shen WL; Shen Y; Yan SG; Luo Y; Low BC; Ouyang H; Bao Z; Zheng LL; Zhou YT
    Mol Cell Biol; 2018 Dec; 38(24):. PubMed ID: 30275345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trpc1 ion channel modulates phosphatidylinositol 3-kinase/Akt pathway during myoblast differentiation and muscle regeneration.
    Zanou N; Schakman O; Louis P; Ruegg UT; Dietrich A; Birnbaumer L; Gailly P
    J Biol Chem; 2012 Apr; 287(18):14524-34. PubMed ID: 22399301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-II is regulated by microRNA-125b in skeletal myogenesis.
    Ge Y; Sun Y; Chen J
    J Cell Biol; 2011 Jan; 192(1):69-81. PubMed ID: 21200031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncIRS1 controls muscle atrophy via sponging miR-15 family to activate IGF1-PI3K/AKT pathway.
    Li Z; Cai B; Abdalla BA; Zhu X; Zheng M; Han P; Nie Q; Zhang X
    J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):391-410. PubMed ID: 30701698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanidinoacetic Acid Regulates Myogenic Differentiation and Muscle Growth Through miR-133a-3p and miR-1a-3p Co-mediated Akt/mTOR/S6K Signaling Pathway.
    Wang Y; Ma J; Qiu W; Zhang J; Feng S; Zhou X; Wang X; Jin L; Long K; Liu L; Xiao W; Tang Q; Zhu L; Jiang Y; Li X; Li M
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
    Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
    Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.